rinary follicle stimulating hormone (FSH) usage in in vitro fertilisation (IVF) cycles

Not Applicable

Completed

• Conditions: Primary infertility; Pregnancy and Childbirth; Infertility

• Registration Number: ISRCTN55462029
• Lead Sponsor: Bahceci Women Health Care Center (Turkey)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-06-23
• Study Completion: 2008-11-30
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

1. Women less than 42 years old
2. Healthy

Exclusion Criteria

1. Any of the ovary removed surgically
2. Surgically retrieved spermatozoa
3. FSH level over 13 mIU/ml

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of oocytes retrieved, 12 days following embryo transfer.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Pregnancy rate<br> 2. Implantation rate<br> 3. Duration of stimulation<br> 4. Gonadotropin consumption<br><br> All secondary outcomes measured at 12 days following embryo transfer.<br>